|
click image for more details
|
Drosophila
We have carried out an integrative functional analysis on a variety of muscle proteins using the Drosophila model. Proteins include the myosin regulatory light chain, myosin, flightin, projectin, tropomyosin, and metabolic enzymes. For example, in a study of 3 phosphorylation site mutations in the regulatory light chain (RLC), we were able to trace deficiencies in oscillatory power from the molecular level to the organismal level. We demonstrated a graded reduction in mechanical and metabolic power production, wing beat frequency, and flight ability. X-ray diffraction studies in living flies confirmed that a reduced recruitment of power-generating cross-bridges underlay the drop in power output.
|
click image for more details |
Mouse
Mouse models of human diseases have become very important for the better understanding and treatment of humans. Familial hypertropohic cardiomyopathy, in particular, is a class of human heart disease caused by mutant genes for sarcomeric proteins and lends itself very well to study through transgenic mice. Mice possessing a specific genetic defect have been generated by our collaborators (Dr. Seidman and Dr. Robbins). We study the mechanical and kinetic consequences of the the genetic defects in thin strips of heart muscle. Because these specific genetic defects may or may not lead to precitable protein defects, these studies are shedding light onto the coupling of protein expression and its mechanical consequences.
|
click image for more details |
Human
We are applying the techniques and knowledge gained from transgenic fly and mouse animal studies to human muscle. Our goal is to understand the molecular basis of clinically and epidemiologically important diseases, with the ultimate aim of designing methods of diagnoses and treatment. Diabetic cardiomyopathy is one example. With our collaborating surgeons (Dr. Frank Ittleman) we have discovered specific, potentially deleterious alterations of dynamic stiffness that occur in left ventricular tissue from diabetic patients. As a group we are using the latest advances in immunohistochemistry, protein analysis, and biomechanical engineering to assess the contribution of connective tissue proliferation, isoform shifts and post-translational changes in myofibrillar proteins to disease-related alterations of human cardiac and skeletal muscle performance.
|